- Exchange: Frankfurt
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Raptor Pharmaceutical Corp
+ Add to WatchlistXYXR:GR
4.561 EUR 0.023 0.51%As of 10:12:19 ET on 05/17/2013.
Snapshot for Raptor Pharmaceutical Corp (XYXR)
| Open: | 4.544 | Day's Range: | 4.543 - 4.580 | Volume: | 976 |
|---|---|---|---|---|---|
| Previous Close: | 4.538 | 52wk Range: | 3.388 - 5.493 | 1-Yr Rtn: | +10.20% |
Key Statistics for XYXR
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. DAX | - |
| Earnings Per Share (USD) (ttm) | - |
| Est. EPS (USD) (12/2013) | -1.0820 |
| Est. PEG Ratio | - |
| Market Cap (M EUR) | 0.00 |
| Shares Outstanding (M) | 0.00 |
| 30 Day Average Volume | 403 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 07/10/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for XYXR
Company Profile & Key Executives for XYXR
Raptor Pharmaceuticals Corporation researches existing drugs to improve them through specialized drug targeting methods and formulation changes.
| Christopher M StarrChief Executive Officer | Georgia ErbezCFO/Treasurer/Secretary |
| Todd C ZankelChief Scientific Officer | Julie Anne SmithExec VP:Strategy/COO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
XYXR News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page